Back
Pasithea Therapeutics Corp. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67
KTTA
Pasithea Therapeutics Corp.
Last Price:
$1.16
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KTTA is experiencing slight buying pressure.
Pasithea Therapeutics Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.14 | Buy |
| 20-day SMA: | 1.09 | Buy |
| 50-day SMA: | 0.86 | Buy |
| 200-day SMA: | 0.91 | Buy |
| 8-day EMA: | 1.14 | Buy |
| 20-day EMA: | 1.06 | Buy |
| 50-day EMA: | 0.85 | Buy |
| 200-day EMA: | 0.38 | Buy |
Pasithea Therapeutics Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.68 | Buy |
| Chaikin Money Flow: | 153315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 1.29) | Buy |
| Bollinger Bands (100): | (0.61 - 0.99) | Buy |
Pasithea Therapeutics Corp. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pasithea Therapeutics Corp. Stock
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 1.18 while KTTA 8-day simple moving average is 1.14, which is a Buy signal.
-
The stock price of KTTA is 1.18 while Pasithea Therapeutics Corp. 20-day SMA is 1.09, which makes it a Buy.
-
Pasithea Therapeutics Corp. 50-day simple moving average is 0.86 while KTTA share price is 1.18, making it a Buy technically.
-
KTTA stock price is 1.18 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.91, creating a Buy signal.
KTTA Technical Analysis vs Fundamental Analysis
Buy
67
Pasithea Therapeutics Corp. (KTTA)
is a Buy
Is Pasithea Therapeutics Corp. a Buy or a Sell?
-
Pasithea Therapeutics Corp. stock is rated a BuyThe current Pasithea Therapeutics Corp. [KTTA] share price is $1.18. The Score for KTTA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Pasithea Therapeutics Corp. Stock Info
Market Cap:
8.8M
Price in USD:
1.18
Share Volume:
467.4K
Pasithea Therapeutics Corp. 52-Week Range
52-Week High:
3.85
52-Week Low:
0.28
Buy
67
Pasithea Therapeutics Corp. (KTTA)
is a Buy
Pasithea Therapeutics Corp. Share Price Forecast
-
What is the Pasithea Therapeutics Corp. stock price today?The Pasithea Therapeutics Corp. stock price is 1.18 USD today.
-
Will KTTA stock go up or go down?Pasithea Therapeutics Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Pasithea Therapeutics Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pasithea Therapeutics Corp. is not overvalued.
Is Pasithea Therapeutics Corp. Stock a Buy?
-
Pasithea Therapeutics Corp. share price is 1.18 while KTTA 8-day exponential moving average is 1.14, which is a Buy signal.
-
The stock price of KTTA is 1.18 while Pasithea Therapeutics Corp. 20-day EMA is 1.06, which makes it a Buy.
-
Pasithea Therapeutics Corp. 50-day exponential moving average is 0.85 while KTTA share price is 1.18, making it a Buy technically.
-
KTTA stock price is 1.18 and Pasithea Therapeutics Corp. 200-day simple moving average is 0.38, creating a Buy signal.
Fundamental Analysis of Pasithea Therapeutics Corp.
Is Pasithea Therapeutics Corp. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.82 per share.
Technical Analysis of Pasithea Therapeutics Corp.
Should I short Pasithea Therapeutics Corp. stock?
-
KTTA Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Pasithea Therapeutics Corp. is a Buy
-
Pasithea Therapeutics Corp. Relative Strength Index (RSI) is 60.68, which suggest Pasithea Therapeutics Corp. is overbought
-
The Bollinger Bands (25) for Pasithea Therapeutics Corp. is (0.67 - 1.29), which suggest Pasithea Therapeutics Corp. is a Buy
-
The Bollinger Bands (100) for Pasithea Therapeutics Corp. is (0.61 - 0.99), which suggest Pasithea Therapeutics Corp. is a Buy
* Pasithea Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.